Literature DB >> 1849272

Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing.

W L Xie1, J G Chipman, D L Robertson, R L Erikson, D L Simmons.   

Abstract

Rous sarcoma virus was shown to induce in chicken embryo fibroblasts (CEF) a 4.1-kilobase mRNA (designated CEF-147) encoding a 603-amino acid protein. Analysis of the protein sequence showed that it shared 59% amino acid identity with sheep prostaglandin G/H synthase, the enzyme that catalyzes the rate-limiting steps in the production of prostaglandins. Significant differences, at both the protein and mRNA levels, existed between the src oncogene product-inducible prostaglandin synthase and the protein isolated and cloned from sheep seminal vesicle, suggesting that the src-inducible prostaglandin synthase may be a new form of the enzyme. A distinguishing feature of src-inducible prostaglandin synthase mRNA is its low abundance in nonproliferating chicken embryo fibroblasts and its relatively high abundance in src-transformed cells. Additionally, the majority of the src-inducible prostaglandin synthase RNA present in nonproliferating cells was found to be nonfunctional because of the presence of an unspliced intron that separated the signal peptide from the remainder of the protein. Upon mitogenic stimulation, this intron was removed, resulting in the induction of fully-spliced CEF-147 mRNA.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1849272      PMCID: PMC51304          DOI: 10.1073/pnas.88.7.2692

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Constitutive expression of a gene encoding a polypeptide homologous to biologically active human platelet protein in Rous sarcoma virus-transformed fibroblasts.

Authors:  P A Bedard; D Alcorta; D L Simmons; K C Luk; R L Erikson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

2.  Stimulation of prostaglandin E2 synthesis in cloned osteoblastic cells of mouse (MC3T3-E1) by epidermal growth factor.

Authors:  K Yokota; M Kusaka; T Ohshima; S Yamamoto; N Kurihara; T Yoshino; M Kumegawa
Journal:  J Biol Chem       Date:  1986-11-25       Impact factor: 5.157

3.  A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation.

Authors:  G Shaw; R Kamen
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Isolation and characterization of the complementary DNA for sheep seminal vesicle prostaglandin endoperoxide synthase (cyclooxygenase).

Authors:  J P Merlie; D Fagan; J Mudd; P Needleman
Journal:  J Biol Chem       Date:  1988-03-15       Impact factor: 5.157

6.  Transformation by Rous sarcoma virus induces a novel gene with homology to a mitogenic platelet protein.

Authors:  S Sugano; M Y Stoeckle; H Hanafusa
Journal:  Cell       Date:  1987-05-08       Impact factor: 41.582

7.  Possible induction of fatty acid cyclooxygenase in mouse osteoblastic cells (MC3T3-E1) by cAMP.

Authors:  M Kusaka; T Oshima; K Yokota; S Yamamoto; M Kumegawa
Journal:  Biochim Biophys Acta       Date:  1988-12-09

8.  Evidence of protein kinase C involvement in phorbol diester-stimulated arachidonic acid release and prostaglandin synthesis.

Authors:  J Parker; L W Daniel; M Waite
Journal:  J Biol Chem       Date:  1987-04-15       Impact factor: 5.157

9.  Epidermal growth factor stimulation of prostaglandin E2 biosynthesis in amnion cells. Induction of prostaglandin H2 synthase.

Authors:  M L Casey; K Korte; P C MacDonald
Journal:  J Biol Chem       Date:  1988-06-05       Impact factor: 5.157

10.  Differential proliferative response to linoleate in cultures of epithelial cells from normal human breast and fibroadenomas.

Authors:  A Balakrishnan; S Cramer; G K Bandyopadhyay; W Imagawa; J Yang; J Elias; C W Beattie; T K Das Gupta; S Nandi
Journal:  Cancer Res       Date:  1989-02-15       Impact factor: 12.701

View more
  234 in total

1.  A771726, the active metabolite of leflunomide, directly inhibits the activity of cyclo-oxygenase-2 in vitro and in vivo in a substrate-sensitive manner.

Authors:  L C Hamilton; I Vojnovic; T D Warner
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

2.  Induction of an acetaminophen-sensitive cyclooxygenase with reduced sensitivity to nonsteroid antiinflammatory drugs.

Authors:  D L Simmons; R M Botting; P M Robertson; M L Madsen; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

3.  COX-1 and COX-2 products in the gut: therapeutic impact of COX-2 inhibitors.

Authors:  B J Whittle
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

Review 4.  COX-2 and cancer: a new approach to an old problem.

Authors:  Y S Bakhle
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

Review 5.  COX in a crystal ball: current status and future promise of prostaglandin research.

Authors:  G A FitzGerald; P Loll
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

Review 6.  Aspirin and other anti-inflammatory drugs.

Authors:  S J Vane
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

Review 7.  Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?

Authors:  Timothy D Warner; Jane A Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-08       Impact factor: 11.205

8.  Raised levels of F(2)-isoprostanes and prostaglandin F(2alpha) in different rheumatic diseases.

Authors:  S Basu; M Whiteman; D L Mattey; B Halliwell
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

9.  Beta-cell specific production of IL6 in conjunction with a mainly intracellular but not mainly surface viral protein causes diabetes.

Authors:  Tom L Van Belle; Philippe P Pagni; Jeanette Liao; Sowbarnika Sachithanantham; Amy Dave; Amira Bel Hani; Yulia Manenkova; Natalie Amirian; Cheng Yang; Bret Morin; Haiqing Zhang; Iain L Campbell; Matthias G von Herrath
Journal:  J Autoimmun       Date:  2014-02-26       Impact factor: 7.094

Review 10.  Clinical use and pharmacological properties of selective COX-2 inhibitors.

Authors:  Shaojun Shi; Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2007-11-13       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.